Clinical Trial Update: Pomegranate Extract Biomarker Study in Osteopenic Women [Phase 1]

View source ↗

Summary

Phase 1 biomarker study assessing pomegranate extract in osteopenic women has completed. The trial was sponsored by POM Wonderful LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteopenia

Drugs mentioned

• Pomegranate Extract

Snippet

Sponsor: POM Wonderful LLC | Conditions: Osteopenic Women | Phase 1 | Status: COMPLETED